| __timestamp | CRISPR Therapeutics AG | HUTCHMED (China) Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1513000 | 33472000 |
| Thursday, January 1, 2015 | 12573000 | 47368000 |
| Friday, January 1, 2016 | 42238000 | 66871000 |
| Sunday, January 1, 2017 | 69800000 | 50675000 |
| Monday, January 1, 2018 | 113773000 | 78821000 |
| Tuesday, January 1, 2019 | 179362000 | 91944000 |
| Wednesday, January 1, 2020 | 266946000 | 111234000 |
| Friday, January 1, 2021 | 438633000 | 207447000 |
| Saturday, January 1, 2022 | 461645000 | 267587000 |
| Sunday, January 1, 2023 | 387332000 | 303055000 |
| Monday, January 1, 2024 | 320653000 |
Unleashing insights
In the dynamic world of biotechnology, innovation is the lifeblood that propels companies forward. Over the past decade, CRISPR Therapeutics AG and HUTCHMED (China) Limited have been at the forefront of this innovation race. From 2014 to 2023, CRISPR Therapeutics AG has consistently outpaced HUTCHMED in research and development (R&D) spending, with a staggering 150% increase in their R&D budget. By 2023, CRISPR's investment in innovation reached nearly 39% more than HUTCHMED's. This trend underscores CRISPR's commitment to pioneering advancements in gene editing technologies. Meanwhile, HUTCHMED has shown a steady growth trajectory, doubling its R&D expenses over the same period, reflecting its strategic focus on expanding its oncology pipeline. As these two giants continue to invest heavily in R&D, the biotech industry eagerly anticipates the groundbreaking therapies that will emerge from their labs.
Analyzing R&D Budgets: Amgen Inc. vs HUTCHMED (China) Limited
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs CRISPR Therapeutics AG
Takeda Pharmaceutical Company Limited or HUTCHMED (China) Limited: Who Invests More in Innovation?
Biogen Inc. or HUTCHMED (China) Limited: Who Invests More in Innovation?
R&D Insights: How Neurocrine Biosciences, Inc. and CRISPR Therapeutics AG Allocate Funds
Comparing Innovation Spending: Madrigal Pharmaceuticals, Inc. and HUTCHMED (China) Limited
Research and Development Investment: Grifols, S.A. vs HUTCHMED (China) Limited
Viking Therapeutics, Inc. or CRISPR Therapeutics AG: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Viking Therapeutics, Inc. vs HUTCHMED (China) Limited
CRISPR Therapeutics AG or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
Analyzing R&D Budgets: CRISPR Therapeutics AG vs Geron Corporation
Analyzing R&D Budgets: HUTCHMED (China) Limited vs Geron Corporation